Clinical Trial Results


There are three completed clinical trials for Apatone and IC-MedTech is working toward conducting more. Two early phase trials were conducted in cancer and one early phase trial was conducted examining the effects on pseudotumors in patients with non-infected symptomatic postoperative total joint arthroplasties.  

The company has worked for years now developing an oral dose form acceptable the FDA. Once that work is concluded, IC-MedTech intends to conduct further clinical trials aimed at satisfying the regulatory requirements. The trial results are listed beginning with the most recent:

Secondary: Deoxypyridinoline Levels [ Time Frame: Baseline and 13 Weeks ]

Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements (Apatone-B)

A 12 Week, Open Label, Phase I/IIa Study Using Apatone® for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy

Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer.